OR WAIT null SECS
April 07, 2022
INCOG Biopharma has completed the construction of its cleanroom production area, marking a milestone in the completion of an overall $100 million investment in a new facility.
April 02, 2022
The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs.
March 08, 2022
G-CON’s signature standardPOD cleanrooms will now be available in Europe.
February 23, 2022
Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.
December 13, 2021
SKAN’s new Cellana isolator is designed for GMP manufacturing of ATMPs.
Fareva plans to use blow-fill-seal equipment and ApiJect’s prefilled injector technology to create fill/finish capacity in France.
New processes, automation, and digitalization were highlighted in 2021.
December 03, 2021
Isolators move into smaller-volume processes, including cell and gene therapy manufacturing.
December 02, 2021
Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.
November 19, 2021
Jordi Serrat, Product & Technology Director, Azbil Telstar talks about the role of disruptive and digital technologies in aseptic processing.